Neural crest development and neuroblastoma: The genetic and biological link

Progress in Brain Research

Volumn 146, Issue , 2004, Pages 231-242

  Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

MYCN oncogene; MYCN oncoprotein; Neuroblastoma; NGF; p75NTR; Stem cells; TrkA

Indexed keywords

NEUROTROPHIN RECEPTOR; PROTEIN P75; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; APOPTOSIS; CELL DIFFERENTIATION; CONFERENCE PAPER; GENE AMPLIFICATION; GENETIC LINKAGE; HUMAN; MYCN ONCOGENE; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST; NEUROBLASTOMA; ONCOGENE; PHENOTYPE; PLOIDY; PRIORITY JOURNAL; PROTEIN FUNCTION; SOLID TUMOR; TUMOR GROWTH; TUMOR REGRESSION;

EID: 0347480302     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(03)46015-9     Document Type: Conference Paper

References (38)

1. Beckwith, J.B. and Perrin, E.V. (1963) In situ neuroblastomas: A contribution to the natural history of neural crest tumors. Am. J. Pathol., 43: 1089-1101.
2. Bessho, F. (1996) Where should neuroblastoma mass screening go? Lancet, 348: 1682-1687.
3. Bolande, R.P. (1974) The neurocristopathies: A unifying concept of disease arising in neural crest maldevelopment. Human Pathol., 5: 409-429.
4. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. and Bishop, J.M. (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224: 1121-1124.
5. Brodeur, G.M. (2003) Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer, 3: 203-216.
6. Casciano, I., Mazzocco, K., Boni, L., Pagnan, G., Banelli, B., Allemanni, G., Ponzoni, M., Tonini, G.P. and Romani, M. (2002) Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ., 9: 246-251.
7. Guillemot, F., Lo, L.C., Johnson, J.E., Auerbach, A., Anderson, D.J. and Joyner, A.L. (1993) Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell, 75: 463-476.
8. Guo, C., White, P.S., Weiss, M.J., Hogarty, M.D., Thompson, P.M., Stram, D.O., Gerbing, R., Matthay, K.K., Seeger, R.C., Brodeur, G.M. and Maris, J.M. (1999) Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene, 18: 4948-4957.
9. Hishiki, T., Nimura, Y., Isogai, E., Kondo, K., Ichimiya, S, Nakamura, Y., Ozaki, T., Sakiyama, S., Hirose, M., Seki, N., Takahashi, H., Ohnuma, N., Tanabe, M. and Nakagawara, A. (1998) Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2. Cancer Res., 58: 2158-2165.
10. Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., Kaneko, Y., McKeon, F., Caput, D. and Nakagawara, A. (1999) p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene, 18: 1061-1066.
11. Ichimiya, S., Nimura, Y., Seki, N., Ozaki, T., Nagase, T. and Nakagawara, A. (2001) Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines. Med. Pediatr. Oncol., 36: 132-134.
12. Ikawa, S., Nakagawara, A. and Ikawa, Y. (1999) p53 family genes: structural comparison, expression and mutation. Cell Death Differ., 6: 1154-1161.
13. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. and Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819.
14. Kaneko, Y. and Knudson, A.G. (2000) Mechanism and relevance of ploidy in neuroblastoma. Genes Chrom. Cancer, 29: 89-95.
15. Lasorella, A., Noseda, M., Beyna, M., Yokota, Y. and Iavarone, A. (2000) Id2 is a retinoblastoma protein target and mediates signaling by Myc oncoproteins. Nature, 407: 592-598.
16. Matsumoto, K., Wada, R.K., Yamashiro, J.M., Kaplan, D.R. and Thiele, C.J. (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55: 1798-1806.
17. McMahon, S.B., Armanini, M.P., Ling, L.H. and Phillips, H.S. (1994) Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron, 12: 1161-1171.
18. Moll, U.M., LaQuaglia, M., Benard, J. and Riou, G. (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA, 92: 4407-4411.
19. Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K.K., Todo, S., Mizuguchi, H., Hayakawa, T. and Nakagawara, A. (2002) Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol. Cell. Biol., 22: 2575-2585.
20. Nakagawara, A., Ikeda, K., Higashi, K. and Sasazuki, T. (1990) Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma. Surgery, 107: 43-49.
21. Nakagawara, A., Arima, M., Azar, C.G., Scavarda, N.J. and Brodeur, G.M. (1992) Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res., 52: 1364-1368.
22. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N.J., Azar, C.G., Cantor, A.B. and Brodeur, G.M. (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328: 847-854.
23. Nakagawara, A., Azar, C.G., Scavarda, N.J. and Brodeur, G.M. (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol., 14: 759-767.
24. Nakagawara, A., Milbrandt, J., Muramatsu, T., Deuel, T.F., Zhao, H., Cnaan, A. and Brodeur, G.M. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res., 55: 1792-1797.
25. Nakagawara, A. (1998a) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum. Cell, 11: 115-124.
26. Nakagawara, A. (1998b) The NGF story and neuroblastoma. Med. Pediatr. Oncol., 31: 113-115.
27. Nakagawara, A. (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett., 169: 107-114.
28. Nikolaev, A.Y., Li, M., Puskas, N., Qin, J. and Gu, W. (2003) Parc: a cytoplasmic anchor for p53. Cell, 112: 29-40.
29. Ohira, M., Shishikura, T., Kawamoto, T., Inuzuka, H., Morohashi, A., Takayasu, H., Kageyama, H., Takada, N., Takahashi, M., Sakiyama, S., Suzuki, Y., Sugano, S., Kuma, H., Nozawa, I. and Nakagawara, A. (2000) Hunting the subset-specific genes of neuroblastoma: expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries. Med. Pediatr. Oncol., 35: 547-549.
30. Ohira, M., Morohashi, A., Inuzuka, H., Shishikura, T., Kawamoto, T., Kageyama, H., Nakamura, Y., Isogai, E., Takayasu, H., Sakiyama, S., Suzuki, Y., Sugano, S., Goto, T., Sato, S. and Nakagawara, A. (2003) Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: Identification of 305 genes differentially expressed between favorable and unfavorable subsets. Oncogene, in press.
31. Ostermeyer, A.G., Runko, E., Winkfield, B., Ahn, B. and Moll, U.M. (1996) Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc. Natl. Acad. Sci. USA, 93: 15190-15194.
32. Pinon, L.G., Minichiello, L., Klein, R. and Davies, A.M. (1996) Timing of neuronal death in trkA, trkB and trkC mutant embryos reveals developmental changes in sensory neuron dependence on Trk signaling. Development, 122: 3255-3261.
33. Pozniak, C.D., Radinovic, S., Yang, A., McKeon, F., Kaplan, D.R. and Miller, F.D. (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science, 289: 304-306.
34. Sawada, T., Hirayama, M., Nakata, T., Takeda, T., Takasugi, N., Mori, T., Maeda, K., Koide, R., Hanawa, Y., Tsunoda, A., et al. (1984) Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group. Lancet, 2: 271-273.
35. Schwab, M., Varmus, H.E., Bishop, J.M., Grzeschik, K.H., Naylor, S.L., Sakaguchi, A.Y., Brodeur, G. and Trent, J. (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature, 308: 288-291.
36. Soderholm, H., Ortoft, E., Johansson, I., Ljungberg, J., Larsson, C., Axelson, H. and Pahlman, S. (1999) Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells. Biochem. Biophys. Res. Commun., 256: 557-563.
37. Tomioka, N., Kobayashi, H., Kageyama, H., Ohira, M., Nakamura, Y., Sasaki, F., Todo, S., Nakagawara, A. and Kaneko, Y. (2003) Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas. Genes Chrom. Cancer, 36: 139-150.
38. Westermann, F. and Schwab, M. (2002) Genetic parameters of neuroblastomas. Cancer Lett., 184: 127-147.